Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-16

Clinical Trial Update: Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating venetoclax with azacitidine for adults with myelodysplastic/myeloproliferative neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)
  • Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Myelodysplastic/Myeloproliferative Neoplasms, Adult | Phase 2 | Status: UNKNOWN